Cervical Medial Branch Block Volume Dependent Dispersion Patterns as a Predictor for Ablation Success: A Cadaveric Study.


Journal

PM & R : the journal of injury, function, and rehabilitation
ISSN: 1934-1563
Titre abrégé: PM R
Pays: United States
ID NLM: 101491319

Informations de publication

Date de publication:
06 2019
Historique:
received: 09 02 2018
accepted: 03 10 2018
pubmed: 28 10 2018
medline: 6 5 2020
entrez: 28 10 2018
Statut: ppublish

Résumé

Neck pain is one of the most common causes of chronic pain and the fourth leading cause of disability worldwide; it is estimated that between 36% and 67% of this pain is due to facet arthropathy. For patients who have pain refractory to conservative treatments literature supports management with diagnostic cervical medial branch blocks (MBBs) to identify the associated facet innervation as the source of pain followed by therapeutic radiofrequency ablation (RFA) of the identified nerves. Cervical RFA has good published outcomes; however, the procedure is dependent upon the specificity of the diagnostic block to achieve maximal success. Currently, this prerequisite test has false positive rates between 27% and 63% and recent studies have shown that this may, in part, be a consequence of currently accepted injection volumes of 0.50 mL or more, which may decrease the sensitivity of MBBs. To evaluate the possible differences in volume dispersion between 0.25 and 0.50 mL of injectate during cervical MBBs. Cadaveric study. An academic medical center in the United States. Not applicable. This was a cadaveric study in which six subjects were chosen with intact cervical spines. Cervical MBB were performed bilaterally at the midcervical spine, using a posterior approach under fluoroscopic guidance. 0.25 or 0.50 mL of a 9:1 solution of Omnipaque 180 mg iodine/mL and 1% medical grade methylene blue were administered on the left and right sides, respectively. Postinjection computed tomography (CT) imaging and gross dissection were performed to assess injectate spread. Outcome measures after using commonly injected volumes for cervical MBB, included visualized and measured spread (by CT and gross dissection) of cervical medial branch blocks, coating adjacent structures not targeted by RFA. Postinjection CT imaging and cadaveric dissection demonstrated that, although both volumes adequately coated the medial branches, the 0.50 mL cohort reliably spread dorsally to superficial muscles (splenius) and nerves distant from the targeted nerves (dorsal motor branches to splenius), whereas the 0.25 mL injectate cohort was contained in the deep and intermediate muscular cervical layers directly juxtaposed to the targeted cMBBs. Results suggest that 0.50 mL injections of local anesthetic during cervical MBBs contacts many nonintended targets, thus decreasing the specificity of a targeted diagnostic cervical MBB. Furthermore, we demonstrated that 0.25 mL of injectate reliably bathed the cervical medial branches without extensive extravasation. This indicates that there would potentially be fewer local anesthetic effects on distant tissues, increasing the specificity of cervical MBBs and likely improving RFA planning.

Sections du résumé

BACKGROUND
Neck pain is one of the most common causes of chronic pain and the fourth leading cause of disability worldwide; it is estimated that between 36% and 67% of this pain is due to facet arthropathy. For patients who have pain refractory to conservative treatments literature supports management with diagnostic cervical medial branch blocks (MBBs) to identify the associated facet innervation as the source of pain followed by therapeutic radiofrequency ablation (RFA) of the identified nerves. Cervical RFA has good published outcomes; however, the procedure is dependent upon the specificity of the diagnostic block to achieve maximal success. Currently, this prerequisite test has false positive rates between 27% and 63% and recent studies have shown that this may, in part, be a consequence of currently accepted injection volumes of 0.50 mL or more, which may decrease the sensitivity of MBBs.
OBJECTIVE
To evaluate the possible differences in volume dispersion between 0.25 and 0.50 mL of injectate during cervical MBBs.
STUDY DESIGN
Cadaveric study.
SETTING
An academic medical center in the United States.
PATIENTS
Not applicable.
METHODS
This was a cadaveric study in which six subjects were chosen with intact cervical spines. Cervical MBB were performed bilaterally at the midcervical spine, using a posterior approach under fluoroscopic guidance. 0.25 or 0.50 mL of a 9:1 solution of Omnipaque 180 mg iodine/mL and 1% medical grade methylene blue were administered on the left and right sides, respectively. Postinjection computed tomography (CT) imaging and gross dissection were performed to assess injectate spread.
MAIN OUTCOME MEASURES
Outcome measures after using commonly injected volumes for cervical MBB, included visualized and measured spread (by CT and gross dissection) of cervical medial branch blocks, coating adjacent structures not targeted by RFA.
RESULTS
Postinjection CT imaging and cadaveric dissection demonstrated that, although both volumes adequately coated the medial branches, the 0.50 mL cohort reliably spread dorsally to superficial muscles (splenius) and nerves distant from the targeted nerves (dorsal motor branches to splenius), whereas the 0.25 mL injectate cohort was contained in the deep and intermediate muscular cervical layers directly juxtaposed to the targeted cMBBs.
CONCLUSION
Results suggest that 0.50 mL injections of local anesthetic during cervical MBBs contacts many nonintended targets, thus decreasing the specificity of a targeted diagnostic cervical MBB. Furthermore, we demonstrated that 0.25 mL of injectate reliably bathed the cervical medial branches without extensive extravasation. This indicates that there would potentially be fewer local anesthetic effects on distant tissues, increasing the specificity of cervical MBBs and likely improving RFA planning.

Identifiants

pubmed: 30367999
pii: S1934-1482(18)31023-2
doi: 10.1016/j.pmrj.2018.10.003
doi:

Substances chimiques

Contrast Media 0
Iohexol 4419T9MX03
Methylene Blue T42P99266K

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

631-639

Informations de copyright

© 2018 American Academy of Physical Medicine and Rehabilitation.

Auteurs

Sayed E Wahezi (SE)

Department of Physical Medicine and Rehabilitation, Department of Anesthesiology, Multidisciplinary Pain Program, 1250 Waters Place, Tower Two, 8th Floor, Bronx, New York 10461.

Jocelin J Molina (JJ)

Department of Anesthesiology, Montefiore Medical Center, 111 East 210th Street, Bronx, NY 10467.

Edward Alexeev (E)

Department of Physical Medicine and Rehabilitation, Montefiore Medical Center, 150 E 210 Street, Bronx, NY 10467.

John S Georgy (JS)

Department of Physical Medicine and Rehabilitation, Montefiore Medical Center, 150 E 210 Street, Bronx, NY 10467.

Nogah Haramati (N)

Department of Radiology, Montefiore Medical Center, 1825 Eastchester Rd, Bronx, NY 10461.

Stephen A Erosa (SA)

Department of Physical Medicine and Rehabilitation, Montefiore Medical Center, 150 E 210 Street, Bronx, NY 10467.

Jay M Shah (JM)

Department of Physical Medicine and Rehabilitation, Montefiore Medical Center, 150 E 210 Street, Bronx, NY 10467.

Sherry Downie (S)

Department of Structural Biology and Anatomy, Department of Physical Medicine and Rehabilitation, 1300 Morris Park Avenue, Bronx, NY 10461.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH